WallStreetZenWallStreetZen

NASDAQ: GLUE
Monte Rosa Therapeutics Inc Stock Ownership - Who owns Monte Rosa Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Monte Rosa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Edmund DunnPrincipal Accounting Officer2025-06-032,062$4.45
$9.17kSell
Chandra P. LeoDirector2025-03-2410,000$5.84
$58.38kBuy
Versant Venture Capital VI LP10% Owner2024-10-2952,305$9.08
$475.03kSell
Versant Venture Capital VI LP10% Owner2024-10-2915,600$9.41
$146.80kSell
Versant Venture Capital VI LP10% Owner2024-10-2889,990$9.66
$869.21kSell
Versant Venture Capital VI LP10% Owner2024-09-201,132,566$6.53
$7.40MSell
Versant Venture Capital VI LP10% Owner2024-09-139,269$6.16
$57.10kSell
Versant Venture Capital VI LP10% Owner2024-09-1216,047$6.00
$96.31kSell
Versant Venture Capital VI LP10% Owner2024-09-11541,897$6.00
$3.25MSell

1 of 1

GLUE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLUE insiders and whales buy or sell their stock.

GLUE Shareholders

What type of owners hold Monte Rosa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bradley J. Phd Bolzon14.46%8,897,053$40.04MInsider
Versant Venture Capital VI LP12.60%7,750,860$34.88MInsider
Ali Behbahani12.51%7,692,298$34.62MInsider
Rick Yang12.51%7,692,298$34.62MInsider
Mohamad Makhzoumi12.51%7,692,298$34.62MInsider
Joshua Makower12.51%7,692,298$34.62MInsider
Scott D. Sandell12.51%7,692,298$34.62MInsider
New Enterprise Associates 17 LP12.51%7,692,298$34.62MInsider
Paul Edward Walker12.51%7,692,298$34.62MInsider
Peter W. Sonsini12.51%7,692,298$34.62MInsider

1 of 3

GLUE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLUE34.01%65.99%Net SellingNet Selling
OCGN17.73%10.44%Net Selling
OMER42.69%5.74%
DSGN45.90%54.10%Net SellingNet Selling
RNAC13.58%86.42%Net Buying
View Top Biotech Stocks

Monte Rosa Therapeutics Stock Ownership FAQ

Who owns Monte Rosa Therapeutics?

Monte Rosa Therapeutics (NASDAQ: GLUE) is owned by 101.06% institutional shareholders, 196.06% Monte Rosa Therapeutics insiders, and 0.00% retail investors. Bradley J. Phd Bolzon is the largest individual Monte Rosa Therapeutics shareholder, owning 8.90M shares representing 14.46% of the company. Bradley J. Phd Bolzon's Monte Rosa Therapeutics shares are currently valued at $42.88M.

If you're new to stock investing, here's how to buy Monte Rosa Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.